Nexien BioPharma (QB) Stock Price - NXEN

0.00 (0.0%)
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Nexien BioPharma Inc (QB) NXEN OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.01575 0.00 0.00 0.00 0.01575 09:33:50
Bid Price Ask Price Spread Spread % News
0.0115 0.015 0.0035 23.33% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.01575 USD

Nexien BioPharma (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 850.25k 53.98M 9.67M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
7.06k $ - 0.00% - -

more financials information »

Nexien BioPharma (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NXEN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.01170.01950.01170.0142494107,0730.0040534.62%
1 Month0.05360.05890.01080.022655939,631-0.03785-70.62%
3 Months0.040.0740.01080.025774419,384-0.02425-60.63%
6 Months0.07410.07410.01080.032089412,014-0.05835-78.74%
1 Year0.0650.100.01080.04667219,675-0.04925-75.77%
3 Years1.206.000.01080.284834819,034-1.18-98.69%
5 Years1.206.000.01080.284834819,034-1.18-98.69%

Nexien BioPharma (QB) Description

Nexien BioPharma Inc. is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid-based pharmaceuticals, in accordance with U.S. Food and Drug Administration ('FDA') pre-clinical and clinical pathways, to address a broad range of medical conditions and disorders. Nexien BioPharma's drug development strategy consists of: A. The determination of medical conditions and disorders that could potentially benefit from cannabinoid-based formulations; B. Conducting "freedom to operate" investigations on these conditions; C. The preparation of patent applications and the prosecution of such application and/or the licensing of existing patents; D. Identifying the regulatory pathway with the FDA; and E. Proceeding with pre-clinical and clinical development activities in accordance with FDA protocols for submission to obtain approval for the particular product(s).

Your Recent History
Nexien Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.